This inventor holds 1 USPTO granted patent and 8 published patent applications. Top assignee: University of California. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Innovations in Atherosclerosis Treatment by Philip Gordts
Introduction
Philip Gordts is an accomplished inventor based in San Diego, California. He has made significant contributions to the field of medical therapies, particularly in the treatment of atherosclerosis and hyperlipidemia. His innovative approach utilizes human milk oligosaccharides to develop effective treatment methods.
Latest Patents
Philip Gordts holds a patent for "Methods and therapies for treating atherosclerosis and/or hyperlipidemia using oligosaccharides." This patent outlines therapies and methods aimed at treating atherosclerosis and hyperlipidemia, along with complications arising from these conditions. The compositions described in the patent include therapeutically effective amounts of one or more human milk oligosaccharides. He has 1 patent to his name.
Career Highlights
Gordts is affiliated with the University of California, where he continues to advance research in his field. His work focuses on developing innovative therapies that can significantly improve patient outcomes in cardiovascular health.
Collaborations
Philip collaborates with notable researchers, including Lars Bode and Ariane Pessentheiner, to further enhance the impact of his work in medical science.
Conclusion
Philip Gordts is a pioneering inventor whose work in treating atherosclerosis and hyperlipidemia showcases the potential of oligosaccharides in medical therapies. His contributions are paving the way for new treatment options in cardiovascular health.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile